These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 377878
1. Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children. Mimouni M, Koivukangas T, Karp M, Laron Z. Acta Diabetol Lat; 1979; 16(1):63-6. PubMed ID: 377878 [Abstract] [Full Text] [Related]
3. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin. Olsson PO, Hans A, Henning VS. Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898 [Abstract] [Full Text] [Related]
4. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins. Hildebrandt P, Birch K, Sestoft L, Vølund A. Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700 [Abstract] [Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB. Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018 [Abstract] [Full Text] [Related]
7. Twenty-four-hour metabolic profiles in diabetic children receiving insulin injections once or twice daily. Werther GA, Jenkins PA, Turner RC, Baum JD. Br Med J; 1980 Aug 09; 281(6237):414-8. PubMed ID: 7000260 [Abstract] [Full Text] [Related]
8. Diurnal blood and urine glucose and acetone bodies in labile juvenile diabetics on one- and two-injection insulin therapy. Akerblom HK, Hiekkala H. Diabetologia; 1970 Apr 09; 6(2):130-4. PubMed ID: 5422442 [No Abstract] [Full Text] [Related]
15. Variability of NPH insulin preparations. Belmonte MM, Colle E, DeBelle R, Murthy DY. Can Med Assoc J; 1971 Jan 23; 104(2):133-8. PubMed ID: 5539004 [Abstract] [Full Text] [Related]
16. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. Bolli GB, Andreoli AM, Lucidi P. Diabetes Technol Ther; 2011 Jun 23; 13 Suppl 1():S43-52. PubMed ID: 21668336 [Abstract] [Full Text] [Related]
17. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB. Diabetes Care; 2003 May 23; 26(5):1490-6. PubMed ID: 12716810 [Abstract] [Full Text] [Related]
18. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus. Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W. Clin Ther; 2006 Dec 23; 28(12):2094-101. PubMed ID: 17296465 [Abstract] [Full Text] [Related]